The efficacy and safety of JAK Inhibitors for Atopic Dermatitis: a systematic review and meta-analysis

CONCLUSIONS: JAK inhibitor was a promising option for atopic dermatitis. More data and surveillance will be needed to identify efficacy, safety, and the risk of adverse effects.PMID:34132163 | DOI:10.1080/09546634.2021.1942422

Source: Journal of Dermatological Treatment - June 16, 2021 Category: Dermatology Authors: Mengyu Miao Lei Ma Source Type: research